online solution: Make a Nursing Care Plan and Drug Study History Profile: BE,

Make a Nursing Care Plan and Drug Study History Profile: BE, a 36-week gestation, 3403-g male infant was born in Canada to immigrants from the Mediterranean region. Pregnancy had been normal. The baby was delivered vaginally by vacuum extraction. Apgar scores were 9 and 9 at 1 and 5 min, respectively. The baby was admitted to the regular nursery, where the receiving nurse noted his skin color to be normal. The admitting physician designated a ‘normal baby’ diagnosis. The baby nursed satisfactorily, passed sufficient stool and urine and was discharged as healthy at age 46 h. Skin color was not documented at discharge and a predischarge bilirubin determination was not performed. Present Assessment: During the first post-discharge day the baby appeared to be doing well. On the fourth day of life, skin color changes were noted. The pediatrician was called and the baby was diagnosed with cutis marmorata based on the mother’s description. The baby was neither examined nor referred to medical assessment. Later that day, when the color changes persisted, the mother took him to the local emergency room, where he was noted by the triage nurse to have the ‘color of a pumpkin’. Vital signs as follows: Temperatue of 37.1 C, pulse rate: 144 bpm, RR: 39 cpm, oxygen saturation: 93-95%. Shortly after arrival, the baby started seizing and stopped breathing. He required full resuscitation, ventilation and admission to the neonatal intensive care unit. Today the baby is severely and irreversibly neurologically and developmentally disabled. The clinical picture is compatible with that of kernicterus. The baby was subsequently found to be G-6-PD deficient.Diagnostic: The serum bilirubin concentration was 38.2 mg per 100 ml. The baby underwent exchange transfusion, following which the serum bilirubin values decreased and hyperbilirubinemia did not recur. Management: Diazepam IV was given as needed for seizure; Administered folic acid syrup.  Reference: M Kaplan, C Hammerman. (2009) The need for neonatal glucose-6-phosphate dehydrogenase screening: a global perspective. Journal of Perinatology 29, S46-S52. doi:10.1038/jp.2008.216 NURSING CARE PLAN FORMATASSESSMENTNURSING DIAGNOSISPLANNINGINTERVENTIONRATIONALEEVALUATIONSubjective: Problem, Etiology, Signs (P.E.S) Format     Short Term Goal: S.M.A.R.T + EvidenceIndependent:  – Assessment – Therapeutic – Educative      Dependent:- Assessment – Therapeutic – Educative      Interdependent/Collaborative:- Assessment – Therapeutic – Educative     Short Term Evaluation:Objective:INFERENCEScientific Explanation (Diagram Form)   Long Term Goal: S.M.A.R.T + EvidenceLong Term Evaluation:DRUG STUDY FORMATDRUG CLASSIFICATIONINDICATIONSSIDE EFFECTSADVERSE EFFECTSNURSING RESPONSIBILITIESGeneric Name:    Brand Name:     Dosage:    Route:    Frequency:             MECHANISM OF ACTIONCONTRAINDICATIONS  Health Science Science NursingNURSING 101